IZI Medical

IZI Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

IZI Medical is a long-established, commercial-stage medical device company focused on interventional oncology and spine procedures. The company operates as a developer, manufacturer, and distributor of a diverse portfolio of consumable devices, selling to over 2,000 domestic customers and across 25 countries internationally. Its strategy centers on partnering with clinicians to innovate in essential but often overlooked procedural areas, and it is supported by the resources of its parent company, Halma plc. IZI's core products include the Quick-Core® Auto Biopsy Needle, Vertefix® MV bone cement, and the Blazer-C Vertebral Augmentation System.

OncologySpine DisordersMusculoskeletal

Technology Platform

Expertise in designing and manufacturing minimally invasive, consumable medical devices for image-guided procedures, with focus on enhanced visualization (e.g., tracking beads), procedural reliability, and integrated system solutions.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The aging global population drives growth in osteoporosis-related spine fractures and cancer diagnostics, increasing demand for IZI's vertebral augmentation and biopsy solutions.
Its focus on integrated, specialized systems for essential but underserved procedures allows it to capture niche market segments with less direct competition from large device conglomerates.
International expansion beyond its current 25 countries, facilitated by parent company Halma's global network, presents a significant growth avenue.

Risk Factors

Revenue is concentrated in niche procedural markets vulnerable to changes in clinical practice or healthcare reimbursement policies.
The company faces intense competition from large, well-resourced medical device companies with broader portfolios.
Its growth-through-acquisition strategy carries execution and integration risks that could disrupt operations.

Competitive Landscape

IZI competes in segmented markets against large, diversified players like Medtronic, Stryker, and Johnson & Johnson DePuy Synthes in spine augmentation, and against BD, Cook Medical, and Argon Medical in the biopsy device space. Its competitive advantage lies in its specialized, physician-collaborative approach and integrated procedural solutions, rather than in competing on scale alone.